SEC Form 4 · accession 0001209191-17-040187
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis Clayton Cantley Jr.
Director
Period of report
Jun 13, 2017
Accepted (ET)
Jun 15, 2017 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Jun 13, 2017 | S | 500 | $50.64 | D | 90,197 | D | |
| Common stockF2,F3 | Jun 13, 2017 | S | 500 | $50.64 | D | 90,237 | I | See footnote |
| Common stockF4 | Jun 14, 2017 | S | 500 | $51.09 | D | 89,697 | D | |
| Common stockF4,F3 | Jun 14, 2017 | S | 500 | $51.09 | D | 89,737 | I | See footnote |
| Common stockF5 | holding | — | — | — | 25,000 | I | See footnote | |
| Common stockF6 | holding | — | — | — | 25,000 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F7 | $50.73 | Jun 13, 2017 | A | 8,500 | A | — | Jun 12, 2027 | Common stock | 8,500 | 8,500 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.10 to $50.97. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- F4The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.28 to $51.43. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
- F6Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.
- F7This option was granted on June 13, 2017. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2018.